Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults

This was a randomized, placebo-controlled, Phase I/II study conducted in a Japanese cohort to assess the safety and immunogenicity of Clostridium difficile vaccine (the same formulation as that used in the ongoing global Phase III study). Healthy Japanese adults aged 40–75 years were randomized to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Osamu, Patel, Dhaval M., Sasaki, Shin, Oka, Hayato, Sasaki, Toru, Pietrobon, Patricia J., Laot, Thelma, Bouckenooghe, Alain, Menezes, Josemund, de Bruyn, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806652/
https://www.ncbi.nlm.nih.gov/pubmed/29116880
http://dx.doi.org/10.1080/21645515.2017.1395538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806652/
https://www.ncbi.nlm.nih.gov/pubmed/29116880
http://dx.doi.org/10.1080/21645515.2017.1395538

Ejemplares similares